‘Exciting' new diagnostic method can detect tiny traces of cancer
Usual tests include blood tests and bone marrow biopsies, CT scans and X rays.
Experts said that this scanning technique can provide an important insight into how well patients are responding to treatment and whether they might relapse.
Myeloma is a type of blood cancer that develops from plasma cells in the bone marrow.
The condition is sometimes called multiple myeloma because it affects more than one part of the body.
The disease is not considered curable but treatment can control it.
Researchers at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, tracked 70 myeloma patients who were having a stem cell transplant.
1/2 Many people living with myeloma experience symptoms for months or even years before receiving a diagnosis.
By sharing this post, you can help raise awareness and make sure more people recognise the warning signs sooner ⚠️ #MyelomaAwarenessWeek #MyelomaWarningSigns pic.twitter.com/hgQTVM5RW0
— Myeloma UK (@MyelomaUK) June 16, 2025
They were all given a whole-body MRI before and after the treatment.
Writing in the Blood Cancer Journal, experts said that one in three patients had signs of residual disease on whole-body MRI after treatment – which can be given to patients without the use of radiation.
Overall survival was also significantly shorter in those with positive MRI findings.
The Royal Marsden has already adopted the the whole-body imagine technique and it could help shape cancer care for patients around the country in the future.
One patient under the treatment of the hospital described how the scanning technique 'extended his life' and enabled him to 'continue serving' the country.
Air Vice-Marshal Fin Monahan, chief fire officer for South Wales Fire and Rescue Service, was diagnosed with myeloma in 2009 while serving in the RAF.
He has since relapsed twice, but thanks to whole-body MRI scans, his cancer was detected much earlier than would have been possible with a traditional CT scan.
The father of three, 57, said: 'With the constant threat of relapse, myeloma patients are in a long-term mental battle with this insidious disease.
'However, being part of the whole-body MRI scan study at the Royal Marsden allowed my cancer to be closely watched and resulted in me being treated sooner than I would have been under normal protocols.
'This not only extended my life but after diagnosis, I returned to flying jets and to active operational duties.
'I would eventually not be allowed to fly on medical grounds due to myeloma but paved the way to establishing the first training programme of Ukrainian forces in 2015 and I was called upon to run Nato air operations after the invasion of Ukraine.
'This cutting-edge treatment not only extended my life but allowed me to continue serving my country.'
Study chief investigator, Professor Christina Messiou, consultant radiologist at The Royal Marsden NHS Foundation Trust, and professor in imaging for personalised oncology at The Institute of Cancer Research, said: 'This study shows that whole-body MRI gives us valuable information about how well the myeloma has responded to treatment that other tests may miss.
'It's exciting that we now have a standardised, non-invasive imaging method that can be used across cancer centres.
'Whole-body MRI doesn't involve radiation or intravenous injections, which is important for patients who may require lifelong monitoring.
'This is an important step towards smarter and kinder precision diagnostics for patients with cancer'
Professor Martin Kaiser, consultant haematologist at The Royal Marsden NHS Foundation Trust and professor in molecular haematology at The Institute of Cancer Research, London, added: 'Access to this gold-standard precision imaging with whole-body MRI has revolutionised care for myeloma patients.
'As the treatment options for myeloma increase and factors such as disease distribution across the body are increasingly understood as important to treatment response, the relevance of the whole-body MRI for personalising treatment will only increase over time.'
Around 6,200 people are diagnosed with the condition each year in the UK and charity Myeloma UK estimates that there are around 33,000 people living with myeloma in the UK.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
21 minutes ago
- Telegraph
Majority of British public back prostate screening
Nine in ten Britons want to see prostate cancer screening introduced, polling has found. A survey of 2,000 adults found widespread problems around the current system, which relies on men to come forward and ask GPs for tests when they already have concerns. Polling of the British public found one in five have had a male family member or close friend die from the disease. Among those, more than three quarters believed earlier diagnosis could have saved the life of their loved one. And more than one quarter of those polled had no trust, or not much trust at all, in the current NHS system to detect prostate cancer at an early stage. The poll found 91 per cent of participants thought the NHS should introduce routine screening for prostate cancer screening in men as it does for breast cancer in women. Women aged between 50 and 70 are offered mammograms every five years. More than half of those polled said their opinion of their local MP would worsen if they opposed the introduction of screening. Targeted screening The research by OnePoll was commissioned by charity Prostate Cancer Research, which is calling for the introduction of targeted screening. The survey found a strong desire among its respondents for the NHS to be more proactive about collecting and sharing information about medical history. In total, 69 per cent of those polled said in the event they were diagnosed with prostate cancer, they would want their male family members' NHS records to be automatically updated to reflect this. Having a family history of the disease – like breast and ovarian disease – means an increased risk. There was also considerable appetite for technological innovation, with 60 per cent supporting the use of artificial intelligence (AI) to improve prostate cancer diagnosis, for example, by reading MRI scans faster and more accurately. The call for targeted screening has been backed by MPs including Rishi Sunak, the former prime minister, Sir James Cleverly, the former home secretary, and Calvin Bailey, a Labour MP and the chairman of the all-party parliamentary group on prostate cancer. Wes Streeting, the Health Secretary, has applauded The Telegraph's campaign, saying he would like to see a screening programme in place if the evidence supports it. David James, the director of patient projects and influencing at Prostate Cancer Research, said: 'These poll results send an unequivocal message to policymakers: the public overwhelmingly supports the introduction of a national prostate cancer screening programme. 'The current system is clearly failing to meet the public's expectations for early detection and proactive management of genetic risk. 'With such strong support for investment and participation, it's time for the NHS to prioritise a targeted screening programme that could save countless lives and alleviate the long-term burden on our healthcare system.' Prostate Cancer Research is calling for urgent improvements to screening provision to tackle rising prostate cancer deaths and health inequality in the UK. The charity's research suggests targeted screening – focused on black men, those with BRCA1/2 mutations and those with a family history of the disease – could mean an extra 775 additional early diagnoses per year for those aged between 45 and 69. The research also suggests these changes could spare almost 300 men a year from a stage 4 diagnosis, in which prostate cancer becomes incurable. A Department for Health and Social Care spokesman said: 'Every life lost to prostate cancer is a tragedy. 'We're working to strengthen cancer services across the NHS and will carefully consider the evidence on prostate cancer screening to ensure we're doing everything possible to catch this disease early and save lives. 'This Government has been clear we would like to see screening in place, but the decision must be evidence-led. 'The UK National Screening Committee is looking at this as a priority, including reviewing the evidence for screening men with a family history of prostate cancer and other high-risk groups. 'While this review takes place, we're getting on with improving cancer treatment and prevention – investing £16m in the TRANSFORM trial to find better detection methods, and deploying cutting-edge technology to personalise medicine, catch sickness sooner, and save lives.'
Daily Mail
3 hours ago
- Daily Mail
FIFO worker Carmen thought she was fit and healthy until a routine check-up turned her life upside down. This is her powerful plea as she fights for life
A fly-in, fly-out worker battling stage four metastatic cancer has urged Australians to 'trust your gut' after her own instincts led to a life-changing diagnosis. Brisbane woman Carmen Keogh, 33, thought she was fit and healthy until a routine check-up in late 2024 turned her life upside down. Despite having no obvious symptoms, a PET scan revealed that her body was riddled with tumours beneath the skin. She's been in the fight of her life ever since. 'There were spots on my liver, lungs, lymph nodes, subcutaneous tissue and on my bones as well,' she told the Daily Mercury. 'I was more in shock than anything, I remember just thinking 'are you sure that's my scan?'' It's believed the cancer spread from a clear, itchy mole Ms Keogh had removed seven years ago. At the time, doctors assured the mole was unproblematic but, knowing her cousin had a similar mole that turned out to be melanoma, Ms Keogh insisted it be removed. After testing identified the mole as a Clark Level IV melanoma, Ms Keogh received treatment and was assured the cancer hadn't spread. After having a second mole removed a few months later, she learned she carried a rare gene mutation and was highly susceptible to cancer. Her worst fears became reality seven years later. Despite knowing cancer was on her 'radar', the extent of the tumours was difficult to reconcile with the absence of symptoms. Ms Keogh underwent five rounds of immunotherapy, which failed to contain the spread. 'Unfortunately it wasn't cancer had progressed,' she said. The only approved option left was therapy tablets, which resulted in rare and frightening side effects early on. Thankfully, the side effects have worn off and the treatment has reduced the visible tumours in her subcutaneous tissue. But Ms Keogh realises she will likely become resistant to the treatment. Had the immunotherapy worked, her oncologist said there was a 62 per cent chance Ms Keogh would still be alive in five years' time. The five-year survival rate for stage four metastatic cancer in Australia is less than 25 per cent. 'But since immunotherapy treatment hasn't worked, I haven't actually asked her what the prognosis is… I don't know if I want to know, if it'll make it worse,' she said. Despite her diagnosis, Ms Keogh juggles endless medical appointments with full-time work on a seven days on/seven-off roster at Hail Creek, an open-cut mine in Queensland's Isaac Region. Ms Keogh understands the importance of trusting your instincts when it comes to health, having lost her own mother to ovarian cancer when she was just 17. 'Don't ignore your body even if you feel healthy, keep up with regular checks and trust your gut if something feels off,' she told the newspaper. Ms Keogh's loved ones have launched a GoFundMe campaign to assist with soaring medical expenses and alternative treatment options. If the current treatment stops working, her last resort will be experimental clinical trials which cost up to $90,000. 'Fighting cancer is hard enough — but fighting to afford to stay alive is an impossible weight,' the fundraiser reads. 'Carmen's hope lies in alternative treatments and clinical trials, which come at a devastating cost: $70,000 to $90,000 — none of it covered by insurance or government funding. 'She's still working full-time, managing endless appointments, and pushing through overwhelming fatigue; however she can't do this alone anymore.' Donations will also allow Ms Keogh to participate in clinical trials, fund scans, medications and hospital visits, and take time off work to focus on recovery. 'Carmen has spent her life facing hardship with quiet strength. We are not asking for anything more than a fighting chance,' the fundraiser added. Despite the terrifying prognosis, Ms Keogh is planning a European holiday for next year and hopes to one day raise a family of her own.
Wales Online
13 hours ago
- Wales Online
12 'Easily dismissed' symptoms of deadly cancer that kills thousands every year
12 'Easily dismissed' symptoms of deadly cancer that kills thousands every year This type of cancer is the fourth most common among men, but it's vague symptoms leaves many simply dismissing the warning signs The subtle signs could be pointing to a number of serious conditions so it's best to consult your GP (Image: GETTY) Head and neck cancer is a group of cancers that originate in the tissues of these body parts, but it doesn't include cancers that start in the thyroid, oesophagus, windpipe or brain according to Macmillan. 12,200 people are diagnosed with head and neck cancer in the UK every year and it's the fourth most common cancer among men. Getting an early diagnosis and swift treatment can have a major impact on both survival and effects of the treatment as 4,100 people lose their lives to these cancers each year in the UK according to Cancer Research. However, many people dismiss the earliest warning signs as it can mimic everyday issues most people face. Medical negligence experts at Simpson Millar say they've also seen a rise in clients who were misdiagnosed, ignored or sent away with antibiotics, only to later receive a life-altering diagnosis. Kate McCue, Senior Associate Solicitor at Simpson Millar, says: "When it comes to head and neck cancer, timing really does make all the difference. 'Catching it early can lead to much better outcomes, not just in terms of survival, but also in how intensive the treatment needs to be, how long recovery takes, and what quality of life looks like after treatment." Common symptoms include: Persistent sore throat Mouth ulcers that don't heal Pain or difficulty swallowing A lump in the neck or mouth Changes in voice or speech Swelling or thickening in the cheek Loose teeth with no obvious cause Unexplained weight loss Ear pain or hearing problems A blocked nose on one side only Numbness in the tongue or lips White or red patches in the mouth If you experience these symptoms for more than two to three weeks or they begin to worsen, it's best to speak to your GP or dentist. The medical negligence experts also urged people to push for further testing if they feel something is wrong or that their symptoms aren't being taken seriously. Kate added: 'Too often, late diagnosis isn't just down to bad luck but a reflection of structural barriers that can and should be addressed. "If we want to reduce avoidable deaths from head and neck cancer, we need to fix the system. That means better access to GP and dental services, more targeted public health outreach, and making early diagnosis the norm.' Article continues below Tests for head and neck cancer can include blood tests, x-rays, CT scans, MRI scans and PET-CT scans or biopsies. If your doctor or dentist believes your symptoms may be pointing to cancer, you will likely get a referral within two weeks to see a specialist. If your only symptom is a lump in your neck, you could be referred to a neck lump clinic. These clinics can conduct ultrasound neck scans, biopsy of the lump and nasendoscopy which looks at the back of your mouth, nose and throat. People who smoke or drink excessively may have a higher risk of head and neck cancer, especially if they do both according to Macmillan. The cancer is also more common in men than women.
